“Does the Prophylactic Use of Palivizumab in Premature Patients With Down Syndrome in Respiratory Syncytial Virus Infection Reduce the Hospitalization Rate? An Integrative Review”. Research, Society and Development 13, no. 1 (January 29, 2024): e13513144288. Accessed January 2, 2026. https://www.rsdjournal.org/rsd/article/view/44288.